No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Nascent Biotech Receives Delinquency Notification Related to Its Delayed September 30, 2024 Financial Filing
NASCENT BIOTECH INC | 10-Q: Q1 2025 Earnings Report
Nascent Biotech Presents at the July Emerging Growth Conference
NASCENT BIOTECH INC | 10-K: FY2024 Annual Report
Nascent Biotech Prepares for Pivotal Phase II Research With Fresh Manufacturing Run
Nascent Biotech Partners With Hypospray Pharma for Transdermal Delivery System